Verona Pharma has claimed FDA approval for its ... killing more than three million people in 2019, according to World Health Organization (WHO) estimates. The massive number of patients with ...

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine, its ...